about
Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disordersProteome analysis of human substantia nigra in Parkinson's diseaseThe prion hypothesis in Parkinson's disease: Braak to the futureOxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseMerging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseElevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cellsMore than a Rumor Spreads in Parkinson's DiseaseAlpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body DisordersThe contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseThe bowel and beyond: the enteric nervous system in neurological disordersMany Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's DiseaseBasal ganglia activity patterns in parkinsonism and computational modeling of their downstream effectsParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisVanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicityAge-dependent motor deficits and dopaminergic dysfunction in DJ-1 null miceAlpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cellsPathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic miceN-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line DataParkinson's Disease and Cognitive ImpairmentLinear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Pathomechanisms and compensatory efforts related to Parkinsonian speech.Perception of speech by individuals with Parkinson's disease: a reviewHigh-level language production in Parkinson's disease: a reviewStartle reflex hyporeactivity in Parkinson's disease: an emotion-specific or arousal-modulated deficit?Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeysCell therapy in Parkinson's diseasePINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathyMechanisms of body weight fluctuations in Parkinson's disease.Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.Targeting impulsivity in Parkinson's disease using atomoxetineCyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus.Reduced hypocretin (orexin) levels in dementia with Lewy bodies.Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's diseaseMitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson diseaseSelective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons.Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.Dopamine effects on identified rat vagal motoneurons
P2860
Q21146612-0304E497-4FA2-4190-AA7A-474B35AEFC75Q21245637-8EA41BD1-9C0F-42C9-A865-9BA21BFBFC1EQ22001062-4AF87BF9-0D29-446C-A639-8CB07B1D47A7Q24337079-5CD6A3DE-B35E-48D4-9967-42B214F4C0C0Q26773485-8E391340-16F1-4D12-8581-FE5A5F2843ABQ27329722-CC7FAC79-ACA8-4774-B5D6-37936B6A122BQ28066571-8AA400FB-A81A-4378-B5D1-73E4F0845C5EQ28067429-3BADE1CE-4206-4EE5-8952-82FC7A999EB7Q28068464-D653C593-B8C2-45C7-9A00-28C1F9A10856Q28069344-2D884616-6BAB-49D0-9424-5C24D2D26237Q28081355-8F95C0C7-055C-445F-ADBF-43D573D26E86Q28271277-F01AA125-7C7D-40B3-BCEB-280D26BE5F5BQ28384572-93F276CC-3FC3-4298-95E8-5953EB0A1B69Q28388187-CBABB390-ED44-4B53-BB03-146974C13AEEQ28507691-F3B3C407-72AD-45D2-8131-9A138B2485F8Q28578806-9B1DC678-3901-4C06-9254-2A0316FF0BB8Q29620597-AFD04CBD-8233-4EE5-8A1B-D72E4BA62744Q30000089-896283FB-0872-41C8-A812-5BF1A1DCC330Q30239814-4EE2BB81-3A36-4DFF-B66E-DBB5B04FC957Q30276531-C1EEE5AC-E424-43DE-980C-AFE6D4520CF4Q30446173-ECFB4A56-66D1-449F-9F64-0012C13E3244Q30474036-7C801FF5-BE66-4B7E-BB90-0B9B80F4C43EQ30474475-EC90029D-2F3B-4BC5-93F0-939A38C45F35Q30480822-2C3BFAFE-A7EA-4C99-83A7-4B4B3C660706Q31059759-61F1EAC7-262D-4378-8785-51CDEB62E3BBQ33212017-4FB2FA50-E62F-409F-994F-964704D2130CQ33619324-05CBE764-C801-4565-942A-5825B05FB03BQ33670282-9ECF2260-D6DA-4436-8BFC-C155BDA601D2Q33693961-FCDBDAEF-CF43-48A2-8882-FBB063C45C84Q33697904-9BDF2A8D-5A8A-426E-AA1A-7A353434F3D6Q33754643-974DC61E-ED59-4E6D-988C-9666D3226CDFQ33784038-ADF2E416-504F-4795-BC0E-38EE59EDCE92Q33836942-3B07E4E6-ACAF-485C-B43B-00F55060E6ADQ34004294-4C2FF5FC-4330-4749-921C-F32AEA584F46Q34013066-ACD95590-C06A-4C0D-8988-8D813464AF57Q34260081-34CC758D-5025-445C-B788-DF4E6B2F4AA8Q34299923-5A47E727-96E3-43DE-A821-70F2DEEDEC77Q34332773-838EDBF0-97BE-41C4-8AA8-1A937DFE1B2AQ34535482-B7C2164E-33BD-4B0F-8DCF-08302935E2E1Q34762829-01D725AD-1605-49D4-85CF-DD45EF702C4E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathoanatomy of Parkinson's disease.
@ast
Pathoanatomy of Parkinson's disease.
@en
Pathoanatomy of Parkinson's disease.
@nl
type
label
Pathoanatomy of Parkinson's disease.
@ast
Pathoanatomy of Parkinson's disease.
@en
Pathoanatomy of Parkinson's disease.
@nl
altLabel
Pathoanatomy of Parkinson’s disease
@en
prefLabel
Pathoanatomy of Parkinson's disease.
@ast
Pathoanatomy of Parkinson's disease.
@en
Pathoanatomy of Parkinson's disease.
@nl
P356
P1433
P1476
Pathoanatomy of Parkinson's disease.
@en
P2888
P304
P356
10.1007/PL00007758
P478
247 Suppl 2
P577
2000-04-01T00:00:00Z
P6179
1052563038